Status:
UNKNOWN
Role of SIRT1 in Regulation of Epithelial-to-mesenchymal Transition in Breast Cancer Lymph Nodes Metastasis
Lead Sponsor:
Peking University People's Hospital
Conditions:
Breast Cancer
Lymph Node Metastases
Eligibility:
FEMALE
Brief Summary
Luminal A breast cancer is a kind of breast cancer with low rate lymph node metastasis and good survival. But in clinical practice, Luminal A breast cancer can present with early, unexpected lymph nod...
Detailed Description
The study has three parts. 1. In large specimens of human Luminal A breast cancer with T1 tumor and positive axillary lymph node, study the difference expression of SIRT1 and related p53, Bcl-2, auto...
Eligibility Criteria
Inclusion
- Invasive breast cancer Luminal A subtype T1 and lymph node positive or T2/T3 with negative lymph node
Exclusion
- Missing clinical pathology data
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2020
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04137406
Start Date
January 1 2019
End Date
December 30 2020
Last Update
October 24 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking university people's hospital
Beijing, Beijing Municipality, China, 100044